The scientists described the cells in “Hydroxamic acid preadsorption raises efficiency of cosensitized solar cells,” which was recently published in Nature. In an accompanying press release ...
CKD is developing non-hydroxamic acid (NHA)-based histone deacetylase 6 (HDAC6) inhibitors for non-oncology indications. CKD’s NHA inhibitors address the limitations of hydroxamic acid (HA ...
Tinostamustine is under clinical development by Northlake International and currently in Phase I for Multiple Myeloma (Kahler Disease).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback